OGI
Price
$0.94
Change
-$0.01 (-1.05%)
Updated
Oct 5 closing price
Capitalization
155.8M
Intraday BUY SELL Signals
TLRY
Price
$3.72
Change
+$0.11 (+3.05%)
Updated
Oct 5 closing price
Capitalization
564.5M
Intraday BUY SELL Signals
Interact to see
Advertisement

OGI vs TLRY

OGI vs TLRY Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
OGI vs. TLRY commentary
Oct 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OGI is a StrongBuy and TLRY is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
OGI vs TLRY: Fundamental Ratings
OGI
TLRY
OUTLOOK RATING
1..100
5164
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
38
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
4692
PRICE GROWTH RATING
1..100
8288
P/E GROWTH RATING
1..100
10090
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OGI's Valuation (33) in the null industry is in the same range as TLRY (38) in the Biotechnology industry. This means that OGI’s stock grew similarly to TLRY’s over the last 12 months.

OGI's Profit vs Risk Rating (100) in the null industry is in the same range as TLRY (100) in the Biotechnology industry. This means that OGI’s stock grew similarly to TLRY’s over the last 12 months.

OGI's SMR Rating (46) in the null industry is somewhat better than the same rating for TLRY (92) in the Biotechnology industry. This means that OGI’s stock grew somewhat faster than TLRY’s over the last 12 months.

OGI's Price Growth Rating (82) in the null industry is in the same range as TLRY (88) in the Biotechnology industry. This means that OGI’s stock grew similarly to TLRY’s over the last 12 months.

TLRY's P/E Growth Rating (90) in the Biotechnology industry is in the same range as OGI (100) in the null industry. This means that TLRY’s stock grew similarly to OGI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OGITLRY
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 7 days ago
83%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
N/A
Bullish Trend 1 day ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
COMPARISON
Comparison
Oct 06, 2026
Stock price -- (OGI: $0.94 vs. TLRY: $3.72)
Brand notoriety: OGI: Not notable vs. TLRY: Notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: OGI: 91% vs. TLRY: 123%
Market capitalization -- OGI: $155.8M vs. TLRY: $564.5M
OGI [@Pharmaceuticals: Generic] is valued at $155.8M. TLRY’s [@Pharmaceuticals: Generic] market capitalization is $564.5M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OGI’s FA Score shows that 1 FA rating(s) are green while TLRY’s FA Score has 0 green FA rating(s).

  • OGI’s FA Score: 1 green, 4 red.
  • TLRY’s FA Score: 0 green, 5 red.
According to our system of comparison, OGI is a better buy in the long-term than TLRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OGI’s TA Score shows that 3 TA indicator(s) are bullish while TLRY’s TA Score has 4 bullish TA indicator(s).

  • OGI’s TA Score: 3 bullish, 6 bearish.
  • TLRY’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, TLRY is a better buy in the short-term than OGI.

Price Growth

OGI (@Pharmaceuticals: Generic) experienced а -13.64% price change this week, while TLRY (@Pharmaceuticals: Generic) price change was -7.46% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -5.56%. For the same industry, the average monthly price growth was -6.33%, and the average quarterly price growth was +26.58%.

Industries' Descriptions

@Pharmaceuticals: Generic (-5.56% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
OGI
Daily Signal:
Gain/Loss:
TLRY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SECT72.880.48
+0.66%
Main Sector Rotation ETF (SECT)
XPND41.080.22
+0.53%
First Trust Expanded Technology ETF (XPND)
TEQI50.890.19
+0.37%
T. Rowe Price Equity Income ETF (TEQI)
UCRD20.490.01
+0.05%
VictoryShares Corporate Bond ETF (UCRD)
MYHE23.83-0.03
-0.13%
State Street My2031 High Yield Corporate Bond ETF (MYHE)

OGI and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGI has been closely correlated with ACB. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if OGI jumps, then ACB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGI
1D Price
Change %
OGI100%
-1.69%
ACB - OGI
69%
Closely correlated
+13.78%
SNDL - OGI
67%
Closely correlated
+0.81%
CGC - OGI
61%
Loosely correlated
+1.04%
TLRY - OGI
52%
Loosely correlated
+3.05%
TRLV - OGI
49%
Loosely correlated
-0.65%
More